Braden Parker

Corporate Officer/Principal at ORCHARD THERAPEUTICS PLC

Health Technology

Consumer Services

Profile

Braden Parker is currently the Chief Commercial Officer at Orchard Therapeutics Plc.
Previously, he worked as the Vice President & General Manager at PTC Therapeutics, Inc. He completed his undergraduate degree at the University of Notre Dame and holds an MBA from The Leonard N Stern School of Business.

Braden Parker active positions

Companies	Position	Start
ORCHARD THERAPEUTICS PLC	Corporate Officer/Principal	-

All active positions of Braden Parker

Former positions of Braden Parker

Companies	Position	End
PTC THERAPEUTICS, INC.	Corporate Officer/Principal	-

See the detail of Braden Parker's experience

Training of Braden Parker

The Leonard N Stern School of Business	Masters Business Admin
University of Notre Dame	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Braden Parker's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PTC THERAPEUTICS, INC.	Health Technology

Private companies	1
Orchard Therapeutics Plc Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.	Health Technology